Participants in the federally legal hemp industry are already required to navigate a complex web of federal and state laws. However, in light of changes that have occurred and will continue to occur throughout 2024, hemp businesses must be prepared to pivot on a moment’s notice throughout the coming months.
Continue Reading Hemp Industry 2024: State and Federal Changes

Tetrahydrocannabinolic acid (THCA) is one of the most misunderstood and controversial cannabinoids in the Cannabis sativa (cannabis) plant. While booming in popularity, THCA is also a high-risk cannabinoid from a legal standpoint.

Following the passage of the 2018 Farm Bill, the marketplace for “alternative” or “minor” cannabinoids – chemical compounds

Continue Reading Is THCA Legal? The State Line is the Bottom Line

Marijuana is currently listed as a Schedule I substance in the Controlled Substances Act (CSA); this scheduling means the federal government concluded marijuana has no currently accepted medical use in any setting. This could change as the Biden Administration evaluates marijuana’s current legal status, potentially opening the door to rescheduling

Continue Reading Rescheduling Marijuana: Understanding the Legal Impacts

The Washington State Liquor and Cannabis Board (LCB) recently adopted an Interpretive Statement on the use of Additives in Authorized Cannabis Products. The Interpretive Statement is described by the LCB as follows:

This interpretive statement describes the use of CBD products and other additives and whether other cannabinoids, such


Continue Reading LCB Interpretive Statement Bans Hemp-Derivatives Besides CBD

On May 19, 2022, the United State Court of Appeals for the Ninth Circuit ruled in a landmark case regarding the legality of delta-8 tetrahydrocannabinol (delta-8 THC). The court held, in AK Futures LLC v. Boyd Street Distro, LLC, that the plain and unambiguous text of the 2018 Agricultural


Continue Reading Federal Court Rules Hemp-Derived Delta-8 THC is Lawful

On May 4, 2022, the Food and Drug Administration (FDA) sent out warning letters to five companies distributing Delta-8 THC (FDA Warning Letters). This is the first time that the FDA specifically addressed products containing hemp-derived Delta-8. In all but one of the letters, the FDA also warned about distributing


Continue Reading The FDA Sets Targets on Delta-8